We go further to deliver insights that empower clients to make business-critical decisions
We deliver meaning to some of the world’s biggest names
Our solutions
We provide flexible solutions within a tech-enabled framework to deliver high quality insights at competitive fixed prices.
Our automated processes mean you pay for value not volume.
Mapping
How do you build an evidence-based communications strategy?
Measuring
How do you quantify the impact of your campaigns and strategies?
Monitoring
How do you distil the world’s media to the coverage you need to see now?
Featured insights
Peptides on X: Mapping the Influence Networks Shaping a High-Stakes Healthcare Debate
Peptides are rapidly emerging as one of the most complex and contested topics in healthcare today, spanning cutting-edge oncology, metabolic disease, and an expanding grey zone of consumer-led experimentation.
To understand how this debate is unfolding, Commetric’s healthcare team analysed global English-language peptide-related conversations on X, not just to measure buzz and hype, but to uncover who drives the conversation, how narratives form, and where influence truly sits.
Weight-loss treatment landscape: global media snapshot
The advent of GLP‑1 medicines has ignited unprecedented worldwide media interest across health, policy, business and culture. Over the past 14 months, fast‑moving narratives have made it increasingly challenging for communicators and decision‑makers to maintain a clear, comparative view of what truly drives conversation, scrutiny and momentum.
Our AI-powered and expert‑interpreted analysis of 15,439 English‑language online news articles (published between January 2025 – February 2026) reveals how governments, companies, innovators and cultural voices are shaping the new obesity‑treatment landscape.
Commetric shortlisted in two categories at the 2026 DataComms Awards
Commetric has been shortlisted in two categories at the 2026 DataComms Awards, hosted by Communicate Magazine / Cravenhill Puiblishing, recognising work that moves communications measurement beyond outputs and towards demonstrable business impact.
The shortlisted entries reflect a shared ambition: to connect media intelligence with real-world outcomes – from market perception to stakeholder influence and strategic decision-making.
Featured insights
Peptides on X: Mapping the Influence Networks Shaping a High-Stakes Healthcare Debate
Peptides are rapidly emerging as one of the most complex and contested topics in healthcare today, spanning cutting-edge oncology, metabolic disease, and an expanding grey zone of consumer-led experimentation.
To understand how this debate is unfolding, Commetric’s healthcare team analysed global English-language peptide-related conversations on X, not just to measure buzz and hype, but to uncover who drives the conversation, how narratives form, and where influence truly sits.
Weight-loss treatment landscape: global media snapshot
The advent of GLP‑1 medicines has ignited unprecedented worldwide media interest across health, policy, business and culture. Over the past 14 months, fast‑moving narratives have made it increasingly challenging for communicators and decision‑makers to maintain a clear, comparative view of what truly drives conversation, scrutiny and momentum.
Our AI-powered and expert‑interpreted analysis of 15,439 English‑language online news articles (published between January 2025 – February 2026) reveals how governments, companies, innovators and cultural voices are shaping the new obesity‑treatment landscape.
Commetric shortlisted in two categories at the 2026 DataComms Awards
Commetric has been shortlisted in two categories at the 2026 DataComms Awards, hosted by Communicate Magazine / Cravenhill Puiblishing, recognising work that moves communications measurement beyond outputs and towards demonstrable business impact.
The shortlisted entries reflect a shared ambition: to connect media intelligence with real-world outcomes – from market perception to stakeholder influence and strategic decision-making.
Need to know more?
Get our latest insights directly to your inbox.





